Skip to Main Content

Author Details

Alan R Fersht
Medical Research Council Laboratory of Molecular Biology
1967
551
127
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34087198AlphaFold - A Personal Perspective on the Impact of Machine Learning.J Mol Biol2021
34089216NF-κB Rel subunit exchange on a physiological timescale.Protein Sci2021
31769931ChemBioChem@20-Some Reflections.Chembiochem2020
31990523Targeting Cavity-Creating p53 Cancer Mutations with Small-Molecule Stabilizers: the Y220X Paradigm.ACS Chem Biol2020
31633398A structure-guided molecular chaperone approach for restoring the transcriptional activity of the p53 cancer mutant Y220C.Future Med Chem2019
31405179SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.Cancers (Basel)2019
29069577Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.Cancer Lett2018
30068941Correction: Energy-dependent nucleolar localization of p53 in vitro requires two discrete regions within the p53 carboxyl terminus.Oncogene2018
29702446Aminobenzothiazole derivatives stabilize the thermolabile p53 cancer mutant Y220C and show anticancer activity in p53-Y220C cell lines.Eur J Med Chem2018
29382728The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53.J Biol Chem2018
28508083Structures of closed and open conformations of dimeric human ATM.Sci Adv2017
28292898Multisite aggregation of p53 and implications for drug rescue.Proc Natl Acad Sci U S A2017
275510772-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.Proc Natl Acad Sci U S A2016
27821763Design of a molecular support for cryo-EM structure determination.Proc Natl Acad Sci U S A2016
27503952An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.Protein Eng Des Sel2016
27267810Harnessing Fluorine-Sulfur Contacts and Multipolar Interactions for the Design of p53 Mutant Y220C Rescue Drugs.ACS Chem Biol2016
27145840The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches.Annu Rev Biochem2016
25675526Mechanism of initiation of aggregation of p53 revealed by Φ-value analysis.Proc Natl Acad Sci U S A2015
26378745Experimental and Theoretical Evaluation of the Ethynyl Moiety as a Halogen Bioisostere.ACS Chem Biol2015
26636255Exploiting Transient Protein States for the Design of Small-Molecule Stabilizers of Mutant p53.Structure2015
25946337Deconvoluting Protein (Un)folding Structural Ensembles Using X-Ray Scattering, Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation.PLoS One2015
25675527Propagation of aggregated p53: Cross-reaction and coaggregation vs. seeding.Proc Natl Acad Sci U S A2015
22777995Intrinsically disordered p53 and its complexes populate compact conformations in the gas phase.Angew Chem Int Ed Engl2013
24277833Profile of Martin Karplus, Michael Levitt, and Arieh Warshel, 2013 nobel laureates in chemistry.Proc Natl Acad Sci U S A2013
24127580MDMX contains an autoinhibitory sequence element.Proc Natl Acad Sci U S A2013
23630318Small molecule induced reactivation of mutant p53 in cancer cells.Nucleic Acids Res2013
23675589Reply to Campos and Muñoz: Why phosphate is a bad buffer for guanidinium chloride titrations.Proc Natl Acad Sci U S A2013
23329326Don't waste good methods on bad buffers and ambiguous data.Proc Natl Acad Sci U S A2013
22176582Long-range modulation of chain motions within the intrinsically disordered transactivation domain of tumor suppressor p53.J Am Chem Soc2012
22972749Domain-domain interactions in full-length p53 and a specific DNA complex probed by methyl NMR spectroscopy.Proc Natl Acad Sci U S A2012
23012405Sequence-dependent sliding kinetics of p53.Proc Natl Acad Sci U S A2012
22955930In support of the BMRB.Nat Struct Mol Biol2012
23035244Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2.Proc Natl Acad Sci U S A2012
23112865Stability of p53 homologs.PLoS One2012
23112193Chemical physics of protein folding.Proc Natl Acad Sci U S A2012
23135266Evaluating Drosophila p53 as a model system for studying cancer mutations.J Biol Chem2012
22869713Kinetic mechanism of p53 oncogenic mutant aggregation and its inhibition.Proc Natl Acad Sci U S A2012
22869710First-order rate-determining aggregation mechanism of p53 and its implications.Proc Natl Acad Sci U S A2012
22439615Halogen-enriched fragment libraries as leads for drug rescue of mutant p53.J Am Chem Soc2012
20650962Highest paraoxonase turnover rate found in a bacterial phosphotriesterase variant.Protein Eng Des Sel2011
21525412Acetylation of lysine 120 of p53 endows DNA-binding specificity at effective physiological salt concentration.Proc Natl Acad Sci U S A2011
21553833Combination of Markov state models and kinetic networks for the analysis of molecular dynamics simulations of peptide folding.J Phys Chem B2011
21639149Nonnative interactions in the FF domain folding pathway from an atomic resolution structure of a sparsely populated intermediate: an NMR relaxation dispersion study.J Am Chem Soc2011
21491862Electrocatalytic monitoring of metal binding and mutation-induced conformational changes in p53 at picomole level.J Am Chem Soc2011
21457718Interaction of the p53 DNA-binding domain with its n-terminal extension modulates the stability of the p53 tetramer.J Mol Biol2011
21422286Malleability of folding intermediates in the homeodomain superfamily.Proc Natl Acad Sci U S A2011
21146541Time-resolved small-angle X-ray scattering study of the folding dynamics of barnase.J Mol Biol2011
21037279Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters.Protein Eng Des Sel2011
21097469Single-Molecule characterization of oligomerization kinetics and equilibria of the tumor suppressor p53.Nucleic Acids Res2011
21187427Folding of the Pit1 homeodomain near the speed limit.Proc Natl Acad Sci U S A2011
  • 1 - 50 of 551

Recommended Authors

Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2000
Number of shared co-authors 1
Eli Lilly and Co.
Career Start Year 1996
Number of shared co-authors 3
Weizmann Institute of Science
Career Start Year 1996
Number of shared co-authors 6
Max-Planck-Institute of Biochemistry
Career Start Year 1995
Number of shared co-authors 3
Weizmann Institute of Science
Career Start Year 1995
Number of shared co-authors 6
Institute for Biophysical Chemistry, Goethe-University
Career Start Year 1995
Number of shared co-authors 6
University of Texas Southwestern Medical Center
Career Start Year 1993
Number of shared co-authors 7
Institute for Biophysical Dynamics, The University of Chicago
Career Start Year 1990
Number of shared co-authors 5
Karolinska Institutet, BioClinicum J6
Career Start Year 1989
Number of shared co-authors 3
Columbia University
Career Start Year 1986
Number of shared co-authors 5
University of Miami Miller School of Medicine
Career Start Year 1986
Number of shared co-authors 2
Indian Institute of Science
Career Start Year 1985
Number of shared co-authors 2
University of Toronto
Career Start Year 1984
Number of shared co-authors 5
Center for Advanced Biotechnology and Medicine, Rutgers University
Career Start Year 1983
Number of shared co-authors 3
Albert Einstein College of Medicine
Career Start Year 1982
Number of shared co-authors 1
Max-Delbruck-Center for Molecular Medicine in the Helmholtz Association (MDC)
Career Start Year 1980
Number of shared co-authors 4
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 5
University of Toronto, University Avenue
Career Start Year 1980
Number of shared co-authors 8
Albert Einstein College of Medicine
Career Start Year 1979
Number of shared co-authors 2
Center for Structural Biology of Infectious Diseases, University of Chicago
Career Start Year 1979
Number of shared co-authors 8
University of California berkeley
Career Start Year 1976
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 5
Rice University
Career Start Year 1974
Number of shared co-authors 6
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 4
Heartand Lung Research Institute, University of Cambridge
Career Start Year 1971
Number of shared co-authors 9
Columbia University Irving Medical Center
Career Start Year 1971
Number of shared co-authors 4
University of California berkeley
Career Start Year 1967
Number of shared co-authors 3
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 4
university of california los angeles
Career Start Year 1963
Number of shared co-authors 7
Harvard University
Career Start Year 1959
Number of shared co-authors 12

Collaborators

Co-authored papers 14
The State University of New Jersey
Co-authored papers 5
Leibniz-Forschungsinstitut fur Molekulare Pharmakologie
Co-authored papers 5
University of Oxford
Co-authored papers 5
National Center for Biotechnology
Co-authored papers 5
University of Toronto
Co-authored papers 4
University of Connecticut Health Center
Co-authored papers 4
The Chinese University of Hong Kong
Co-authored papers 4
Co-authored papers 3
Leicester Institute of Structural and Chemical Biology, University of Leicester
Co-authored papers 2
Columbia University
Co-authored papers 2
National Centre for Biotechnology (CNB CSIC), Campus Universidad Autonoma de Madrid
Co-authored papers 2
Center for Cooperative Research in Biosciences (CIC bioGUNE)
Co-authored papers 2
Imperial College London
Co-authored papers 2
University of Cambridge
Co-authored papers 2
King's College London BHF Centre for Research Excellence
Co-authored papers 2
Medical Research Council Laboratory of Molecular Biology
Co-authored papers 2
National Institutes of Health
Co-authored papers 2
University of California San Francisco
Co-authored papers 1
Center for Integrated Protein Science, Technische Universitat Munchen
Co-authored papers 1
University of Texas Southwestern Medical Center
Co-authored papers 1
The University of Sheffield
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Institute of Systems, The University of Liverpool
Co-authored papers 1
Institute of Integrative Biology, University of Liverpool
Co-authored papers 1
Columbia University
Co-authored papers 1
Zernike Institute for Advanced Materials, University of Groningen
Co-authored papers 1
Co-authored papers 1
University of Oxford
Co-authored papers 1
The Medical Research Council Biomedical NMR Centre, The Francis Crick Institute
Co-authored papers 1